{
    "nctId": "NCT00068341",
    "briefTitle": "Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer",
    "officialTitle": "Neoadjuvant Treatment and Molecular Characterization of Locally Advanced Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 74,
    "primaryOutcomeMeasure": "Evaluate the Objective Response Rate of Patients Treated With Taxotere/Carboplatin With or Without Herceptin Preoperatively.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Confirmed infiltrating adenocarcinoma of the breast\n* Primary breast cancer \\> 5cm, or skin/chest wall involvement, any N, without evidence of metastasis.\n* No prior radiation to the involved breast\n* ECOG (Electrocochleography) performance status 0-2\n* Age 18 years to 80 years\n* Absolute Neutrophil count \\> 1500 cell/\u03bcl, platelet count \\> 100000 cells/\u03bcl and hemoglobin \\> 9 g/dl\n* All liver function tests \\< upper limit of normal\n* Serum creatinine \\< 2.0 mg/dl\n* Normal left ventricular ejection fraction (LVEF) as determined by MUGA (Multiple Gated Acquisition) scan or echocardiogram\n* HER-2/neu status is determined by a FISH (Fluorescence in situ hybridization) test. \\[FISH (+) is HER-2/neu (+)\\]\n* If female of childbearing potential, pregnancy test is negative\n* If premenopausal and not surgically sterilized, the patient agrees to use effective birth control method for the duration of the study\n* Informed consent has been obtained\n\nExclusion Criteria:\n\n* Non-confirmed infiltrating adenocarcinoma breast cancer\n* Evidence of metastasis\n* Previous chemotherapy using the drugs proposed in this study, specifically Herceptin\u00ae, Taxotere\u00ae, and/or Carboplatin\n* Prior radiation to the involved breast\n* Recent breast cancer drug therapy within last 5 years of any form\n* History of allergy to polysorbate or castor oil\n* Ongoing active infection\n* Concurrent life-limiting disease with a life expectancy of less than one year\n* Past or current history of other malignancy within the past 5 years which could affect the diagnosis or assessment of breast cancer, except for curatively treated non-melanoma skin cancer and/or in situ carcinoma of the cervix\n* Pregnancy, nursing, fertile women who do not use birth control device\n* Inability to give informed consent\n* Patients with pre-existing peripheral neuropathy \\> grade 2",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}